Admp Adamis Pharmaceuticals Corp Compare
•
•
2 min read
Yahoo the Daily Biotech Pulse: Karyopharm's Selinexor Review Delayed, Fda Accepts Adamis Opioid Overdose Drug Nda Yahoo Adamis Pharmaceuticals May Report...
|
yahoo
|
The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamis Opioid Overdose Drug NDA
|
|
yahoo
|
Adamis Pharmaceuticals May Report Negative Earnings: Know the Trend Ahead of Q4 Release
|
|
yahoo
|
Before You Buy Adamis Pharmaceuticals Corporation , Consider Its Volatility
|
|
yahoo
|
The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings
|
|
yahoo
|
Is Adamis Pharmaceuticals Corporation Excessively Paying Its CEO?
|
|
yahoo
|
The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US
|
|
yahoo
|
Adamis stock surges on release of EpiPen alternative
|
|
benzinga
|
Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James
|
|
yahoo
|
Adamis Pharmaceuticals Jumps: Stock Rises 5.3%
|
|
zacks
|
Implied Volatility Surging for Adamis Pharmaceuticals Stock Options
|
|
reuters
|
Novartis to launch Adamis' EpiPen rival in U.S. next year
|
|
zacks
|
Teva Launches First Generic Version of Mylan's EpiPen
|
|
zacks
|
Adamis Pharmaceuticals Reports Q3 Loss, Lags Revenue Estimates
|
|
smdailyjournal
|
Adamis: 3Q Earnings Snapshot
|
|
zacks
|
Adamis Pharmaceuticals May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
yahoo
|
Could Adamis Pharmaceuticals Corporation’s Investor Composition Impacts Your Returns?
|
|
yahoo
|
Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Product
|
|
zacks
|
Adamis Pharmaceuticals in Focus: Stock Moves 8% Higher
|
|
zacks
|
Options Traders Expect Huge Moves in Adamis Pharmaceuticals Stock
|
|
yahoo
|
Mylan’s EpiPen Supply Shortages Continue: What to Expect Ahead
|
|
yahoo
|
Teva Gets FDA Nod for First Generic Version of Mylan's EpiPen
|
|
yahoo
|
FDA Approves Teva’s Generic Version of EpiPen, Stock Up 7.5%
|
|
yahoo
|
FDA approves first rival generic EpiPen, sending Teva shares up 6%
|
|
yahoo
|
Adamis: 2Q Earnings Snapshot
|
|
yahoo
|
Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs
|
|
yahoo
|
Adamis Surges Following Novartis Deal for Symjepi
|
